Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Jagsonpal Pharmaceuticals Ltd.

May 18 BSE 361.25 (+ 3.85 1.08%)

Volume575

Prev. Close
357.40

Open Price
357.40

Today's Low / High

351.35 368.25

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

270.05 513.90

May 18 NSE 361.05(+ 3.35 0.94%)

Volume16385

Prev. Close
357.70

Open Price
361.00

Today's Low / High

352.00 375.50

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

273.60 514.85

Standalone

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	5.00	5.00	5.00	5.00	5.00
No. of Equity Shares (in Lacs)	261.98	261.98	261.98	261.98	261.98

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	13.10	13.10	13.10	13.10	13.10
Total Share Capital	13.10	13.10	13.10	13.10	13.10

Revaluation Reserves	0.00	7.84	7.84	7.84	7.84
Reserves and Surplus	145.79	109.92	100.99	90.10	83.53
Total Reserves and Surplus	145.79	117.76	108.83	97.93	91.37
Total Shareholders Funds	158.89	130.86	121.93	111.03	104.47

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	2.16	2.19	1.86	3.09	3.12
Other Long Term Liabilities	5.25	0.00	0.00	0.00	0.00
Long Term Provisions	1.08	1.26	0.02	0.00	0.00
Total Non-Current Liabilities	8.49	3.44	1.88	3.09	3.12

CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	6.79	4.66	3.79
Trade Payables	16.36	16.29	18.05	11.71	11.86
Other Current Liabilities	10.83	17.38	14.71	16.46	12.55
Short Term Provisions	0.38	0.49	0.85	0.00	0.00
Total Current Liabilities	27.57	34.16	40.40	32.83	28.19

Total Capital And Liabilities	194.95	168.45	164.20	146.95	135.78

ASSETS
NON-CURRENT ASSETS
Tangible Assets	24.28	22.37	23.35	22.06	21.61
Intangible Assets	0.00	2.38	2.38	0.03	0.03
Capital Work-In-Progress	0.00	0.00	0.00	1.90	1.89
Intangible Assets Under Development	0.00	0.00	0.00	2.35	2.06
Fixed Assets	24.28	24.75	25.72	26.34	25.60
Non-Current Investments	1.12	20.58	12.06	11.39	0.00
Long Term Loans And Advances	0.00	0.00	0.44	0.00	0.00
Other Non-Current Assets	4.99	12.35	5.50	14.32	12.63
Total Non-Current Assets	30.39	57.68	43.73	52.04	38.23


CURRENT ASSETS
Current Investments	0.00	22.14	3.25	0.00	0.00
Inventories	20.68	29.74	29.72	29.33	32.69
Trade Receivables	20.87	15.58	12.66	21.45	20.75
Cash And Cash Equivalents	114.63	26.15	60.23	38.07	38.53
Short Term Loans And Advances	0.00	0.31	0.27	0.00	0.00
OtherCurrentAssets	8.39	16.86	14.34	6.06	5.58
Total Current Assets	164.56	110.78	120.48	94.91	97.56

Total Assets	194.95	168.45	164.20	146.95	135.78

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	6.09	5.87	5.99	6.06	0.69

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	1.02	20.58	12.06	11.39	0.00

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	5.00
No. of Equity Shares (in Lacs)	261.98

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	13.10
Total Share Capital	13.10
Revaluation Reserves	0.00
Reserves and Surplus	145.79
Total Reserves and Surplus	145.79
Total Shareholders Funds	158.89
NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	2.16
Other Long Term Liabilities	5.25
Long Term Provisions	1.08
Total Non-Current Liabilities	8.49
CURRENT LIABILITIES
Short Term Borrowings	0.00
Trade Payables	16.36
Other Current Liabilities	10.83
Short Term Provisions	0.38
Total Current Liabilities	27.57
Total Capital And Liabilities	194.95
ASSETS
NON-CURRENT ASSETS
Tangible Assets	24.28
Intangible Assets	0.00
Capital Work-In-Progress	0.00
Intangible Assets Under Development	0.00
Fixed Assets	24.28
Non-Current Investments	1.12
Long Term Loans And Advances	0.00
Other Non-Current Assets	4.99
Total Non-Current Assets	30.39
CURRENT ASSETS
Current Investments	0.00
Inventories	20.68
Trade Receivables	20.87
Cash And Cash Equivalents	114.63
Short Term Loans And Advances	0.00
OtherCurrentAssets	8.39
Total Current Assets	164.56
Total Assets	194.95
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	6.09
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	1.02